Personalized medicine and developing world: emerging ethical and policy challenges at the junction of pharmacogenomics laboratory and global society
- At: 2009 FIP Congress in Istanbul (Turkey)
- Type: Presentation
- By: OZDEMIR, Vural (University of Montreal, Montreal, Canada)
There is large inter-individual variability in outcome (benefits/risks) of pharmaceutical interventions. For example, only 50% of patients respond to their prescribed medicines, while serious and fatal adverse drug reactions rank as the fourth leading cause of death, ahead of diabetes and pneumonia. Pharmacogenomics is the study of genomic basis.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.